New estimates highlight need to step up the response to hepatitis D
29 April 2020 – In a study published in the Journal of Hepatology, Professor Anna Maria Geretti and Dr Alexander Stockdale from the University of Liverpool (United Kingdom), in collaboration with researchers from WHO and the International Agency for Research on Cancer (IARC), estimate that worldwide, hepatitis D virus (HDV) affects nearly 5% of people who have a chronic infection with hepatitis B virus (HBV) and that HDV co-infection could explain about 1 in 5 cases of liver disease and liver cancer in people with HBV infection.
Injection safety is improving but more action needed
3 September 2019 – A new journal article states that injection safety is improving, along with reduction in unnecessary injections. However, more action is needed in countries, particularly in the African and the Eastern Mediterranean regions, where a substantial number of unsafe infections is still occurring. The study shows that over 96% of injections in 40 reporting countries were using new safer injection devices in 2011-2015. On average, women received more injections per year (1.85) than men (1.41). Improved injection safety helps to reduce transmission of bloodborne infections such as hepatitis B, C and HIV in health clinics.
15 million people affected with hepatitis B and C in Pakistan. Government announces ambitious plan to eliminate hepatitis
28 July 2019 | Islamabad – Approximately, 5 and 10 million people are affected with hepatitis B and C respectively in Pakistan. Thousands of new patients are added every year due to lack of prevention, testing and treatment resources as well as inadequately screened blood transfusion, improperly sterilized invasive medical devices and unsafe injections. To curb the huge disease burden, the government has announced Prime Minister Imran Khan’s new ambitious plan to eliminate viral hepatitis B and C infections in the country by 2030.
WHO urges countries to invest in eliminating hepatitis
26 July 2019 - Ahead of World Hepatitis Day (28 July), the WHO calls on countries to take advantage of recent reductions in the costs of diagnosing and treating viral hepatitis and scale up investments in disease elimination. A new study by WHO, published today in Lancet Global Health, has found that investing US$6bn per year in eliminating hepatitis in 67 low- and middle-income countries would avert 4.5 million premature deaths by 2030, and more than 26 million deaths beyond that target date.
World Hepatitis Day 2019 - Invest in eliminating hepatitis
During World Hepatitis Day 2019 campaign, WHO is urging all countries and partners to promote the theme “Invest in eliminating hepatitis”. WHO will release new estimates for additional investments needed to achieve globally agreed hepatitis elimination goals by 2030, in the context of the universal health coverage. The host country for World Hepatitis Day 2019 is Pakistan. The global events will be held in Islamabad, Pakistan 27-28 July 2019.
The first African Hepatitis Summit held in Uganda
8 July 2019 – The pioneering event was held in Kampala, Uganda on 18-20 June under the theme: "Eliminating Viral Hepatitis in Africa; Implementing the viral hepatitis strategy". WHO released a new hepatitis scorecard for the implementation of the hepatitis elimination strategy in the region.
More from the WHO African Region website
WHO releases the first integrated progress report on HIV, hepatitis and STIs
23 May 2019 – The new progress report being released today at the 72nd World Health Assembly reviews success and challenges in implementing the global health sector strategies, 2016-2021 on HIV, hepatitis and sexually transmitted infections (STIs). The report also outlines 8 joint actions for accelerating progress towards universal health coverage.
Moving beyond the slogan: “Invest in eliminating hepatitis”
WHO begins guideline development to stop mother-to-child transmission of hepatitis B
HIV and hepatitis news - September 2019
WHO announces Guidelines Development Group for updated guidelines on the public health response for the prevention of mother-to-child transmission of hepatitis B virus infection
15 million people affected with hepatitis B and C in Pakistan: Government announces ambitious plan to eliminate hepatitis
Elimination of hepatitis by 2030